There was no significant difference in the frequency of adverse event and serious laboratory abnormalities between entacapone and placebo groups.
不良事件的发生率与安慰剂组相比差异无显著意义。
Aim: to study the efficacy and safety of entacapone as an adjunct to levodopa treatment in parkinsonian patients with wearing-off motor fluctuations.
目的：探讨添加恩他卡朋治疗帕金森病患者剂末现象的疗效及安全性。
Aim: to study the efficacy and safety of entacapone as an adjunct to levodopa treatment in parkinsonian patients with wearing-off motor fluctuations.
目的：探讨添加恩他卡朋治疗帕金森病患者剂末现象的疗效及安全性。
应用推荐